Lifeboat Foundation

We brought the leading experts in aging research and biotech investment together for an action-packed day of science. See what happened at this exciting event and check out our first event video now.

On July 12th, we hosted our first conference, Ending Age-Related Diseases: Investment Prospects & Advances in Research, at the Frederick P. Rose Auditorium, which is part of the Cooper Union campus in New York City. We are delighted to announce that the conference was a huge success with 160 attendees, a wide variety of speakers from both research and business, and some great discussion panels.

Continue reading “Celebrating Success at Our First Conference” »

New video from Undoing Aging 2018: Doug Ethell, Founder and CEO of Leucadia Therapeutics, presenting: Alzheimer’s Disease Begins as a Fixable Plumbing Problem.

A blood test that detects melanoma in its early stages may allow people to get treatment before the cancer spreads and becomes difficult to cure.

An artificial neural network that’s made entirely from DNA and mimics the way the brain works has been created by scientists in the lab.

The test tube artificial intelligence can solve a classic machine learning problem by correctly identifying handwritten numbers.

Continue reading “Scientists have created an AI inside a test tube using strands of DNA, and they hope it will soon start to form its own ‘memories’” »

“The DNA chaos that CRISPR unleashes has been ‘seriously underestimated,’” study author and geneticist Allan Bradley of U.K.’s Wellcome Sanger Center tells STAT. “This should be a wake-up call.”

Read more toggle.

The brain is about 10% neurons and 90% neural network support cells, called neuroglia, or glial cells, which surround and insulate neurons, protect them from damage, and supply them with nutrients and oxygen. Neuroglia are often found to malfunction in neurological disorders such as Alzheimer’s Disease or amyotrophic lateral sclerosis (ALS).

Research studies indicate that telomerase gene therapy may not only reverse Alzheimer’s Disease and other dementias, but it may even protect people from developing such diseases.

This is indeed hopeful news for the nearly 50 million victims of Alzheimer’s or related dementia worldwide as well as for the millions of aging people with Parkinson’s and aging-related mental decline.

Continue reading “A Novel Gene Therapy To Treat One Of The World’s Biggest Growing Chronic Disease: Dementia and Alzhiemer’s” »

The Nuffield Council on Bioethics says changing the DNA of a human embryo could be ‘morally permissable’ if it is in the child’s best interests.

Ian Sample Science editor.

CTRL-labs’s noninvasive neural interface allows people to control computers, robots and applications by tracking electrical activity generated when a person thinks about moving. This electrical activity is detected by an armband outfitted with sensors and decoded by a computer. The team thinks the technology will initially be used for augmented and virtual reality, but CTRL-labs is already experimenting with medical applications.

CRISPR has been heralded as one of the most important breakthroughs in modern science, but there could be a hidden and potentially dangerous side effect to the wonders of its genetic editing technology, a new study reveals.

A systematic investigation of CRISPR/Cas9 genome editing in mouse and human cells has discovered that the technique appears to frequently cause extensive mutations and genetic damage that the researchers say wouldn’t be detected by existing DNA tests.

“This is the first systematic assessment of unexpected events resulting from CRISPR/Cas9 editing in therapeutically relevant cells,” explains geneticist Allan Bradley from the Wellcome Sanger Institute in the UK.

Continue reading “BREAKING: CRISPR Could Be Causing Extensive Mutations And Genetic Damage After All” »